Lives could be saved with hepatitis C treatment

A research team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths. Hepatitis C virus (HCV) infection is a major public health burden in Australia, with estimates of 230,000 people chronically infected. The research team is calling for the government to subsidise a new therapy which has high cure rates, known as direct acting antiviral (DAA) therapy.

Read the whole article on Science Daily

More from Science Daily